Table 1 Characteristics of subjects
| Â | T2DM | Non-DM Controls |
|---|---|---|
Number | 41 | 40 |
Age (years) | 45 (41–49) | 39 (37–45) |
Duration of DM (years) | 9 (5–12) | NA |
BMI (kg/m2) | 26 (23–31) | 25 (23–29) |
HbA1C (%) | 10 (7.7–11.6) | 5.5 (5.2–5.8) |
Creatinine (mg/dl) | 0.6 (0.5–0.8) | 0.7 (0.6–0.7) |
eGFR (mL/min/1,73 m2) | 106 (87–115) | 110 (106–116) |
SGPT (U/l) | 19 (11–25) | 16 (11–21) |
Triglycerides (mg/dl) | 158 (96–198) | ND |
LDL (mg/dl) | 141 (117–163) | ND |
HDL (mg/dl) | 49 (38–54) | ND |
Total cholesterol (mg/dl) | 197 (179–230) | ND |
Antidiabetics | ||
- Metformin (%) | 7 (17) | NA |
- Metformin + Sulfonylurea (%) | 11 (27) | NA |
- Insulin (%) | 14 (34) | NA |
- Combined therapy (%) | 8 (20) | NA |
- No treatment (%) | 1 (2) | NA |